Goldspan Health review

A single-plan desk with no commitment tiers and no introductory month, selling compounded semaglutide at $229 and tirzepatide at $299 — priced "/month" in the hero and billed every 28 days on the plan card, which is thirteen charges a year.

By Grant Ashford, Founder & Pricing EditorSeptember 2026

Est. first month

From $229

Save ~83% vs brand-name

$229 every 28 days, month-to-month (thirteen charges a year, not twelve)

Get this deal Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Value Score.

Pricing to watch. One plan, one price, no commitment tiers and no introductory month — which removes most of the traps this site looks for. What replaces them is a calendar problem. The hero says "/month"; the plan card says billed every 28 days; the order timeline says the order renews every four weeks. Twenty-eight-day billing comes round thirteen times a year, so $229 a month is $2,977 rather than $2,748, and $299 is $3,887 rather than $3,588 — a difference of about $230 and $300 a year that the word "month" hides. The low-dose lines are the cheap end here: $149 for a daily sublingual semaglutide and $199 for the tirzepatide version, on the same twenty-eight-day cycle.

How much does Goldspan Health cost?

The price Goldspan Health publishes is $229 every 28 days, month-to-month (thirteen charges a year, not twelve). Tirzepatide is listed at $299 every 28 days, month-to-month (thirteen charges a year, not twelve). We flag this one to watch: confirm the ongoing rate with Goldspan Health before you count on it, because a low first month can step up afterward. That works out about 83% under our ~$1,349/mo brand-name cash reference.

Semaglutide: $229 every 28 days, month-to-month (thirteen charges a year, not twelve)
Tirzepatide: $299 every 28 days, month-to-month (thirteen charges a year, not twelve)
Coverage: All 50 states claimed, no list published
Brand-name: Compounded only

The Value Score card

Goldspan Health scored on our six published factors. See the methodology.

Lowest Real Price71/100

No Teaser-Rate Bait64/100

Both Molecules98/100

Nationwide Availability72/100

Easy Cancellation58/100

Reputation66/100

Why it's a deal

One plan and one price per product: no three-, six- or twelve-month ladder, no introductory rate, and nothing to lock into — the commitment trap simply is not present
The catalog is unusually broad and openly priced: injectable and daily sublingual, full dose and low dose, semaglutide and tirzepatide, at $229, $299, $199, $299, $149 and $199 respectively
The pharmacy class is stated plainly — all therapies dispensed by a pharmacy licensed under section 503A or 503B — which is more than most desks put in writing, even though no pharmacy is named
Three clinicians are named with their roles and specialties on the storefront that fulfills the orders, and a phone number is published there
The order timeline tells you when the renewal lands rather than leaving the cadence to be discovered on a card statement, and pausing, delaying or canceling is offered through the portal

Read the fine print

A month here is twenty-eight days. The hero says "/month", the plan card says billed every 28 days and the timeline says every four weeks — thirteen charges a year, so the real annual cost is about $230 higher on semaglutide and $300 higher on tirzepatide than the monthly framing implies
The cancellation promise and the refund policy contradict each other: pause, delay or cancel at any time on one page, all sales final on another, and "once you place an order it cannot be canceled" in the storefront's own terms
The brand publishes no legal entity, no address and no governing law of its own — the only company details on the transaction belong to the storefront that fulfills it
No pharmacy is named, and the clinicians named belong to that storefront while the same storefront states it is not a medical practice
All 50 states is claimed on the homepage while the terms say some therapies are unavailable in certain states, and no list is published either way
The full-dose sublingual products at $199 and $299 are not linked from the weight-loss page, so the cheapest oral route is reachable only by finding the catalog
One product page's inclusion list names the wrong molecule — a tirzepatide page describing compounded sublingual semaglutide — which is the kind of copy error that matters on a prescription product

The bottom line

Best for: Shoppers who want a flat single-tier price with no plan ladder to decode, and who will do the thirteen-charge arithmetic before comparing it with a calendar-month rate. A single-plan desk with no commitment tiers and no introductory month, selling compounded semaglutide at $229 and tirzepatide at $299 — priced "/month" in the hero and billed every 28 days on the plan card, which is thirteen charges a year.

Ranked #218 of 418 programs we track — see our #1 deal, CoreAge Rx, for comparison.

Get this deal

Compare with other deals

The programs scoring closest to Goldspan Health, out of 417 others we track.

Shopping Goldspan Health against a specific rival? We put it head to head with our top-scoring pick on CoreAge Rx vs Goldspan Health, and every program that undercuts or outscores it — starting with PeptidesRx, the closest match on score — is ranked on the Goldspan Health alternatives ranking.

More programs we track (24)

387 more are reviewed too — see every GLP-1 program we track, ranked.

Pricing and coverage on this page were read from Goldspan Health's own website on September 1, 2026; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on Goldspan Health's site. Not medical advice; see our disclosure.

See every program ranked by price →

← Back to all deals